Literature DB >> 2822961

Activation of mutated simian virus 40 enhancers by amplification of wild-type enhancer elements.

J Clarke1, W Herr.   

Abstract

We show that duplication of any one of three separate simian virus 40 enhancer elements, A, B, or C, can compensate for loss of function in the remaining two. Simian virus 40 revertants containing point mutations within the A and C (dpm16) or B and C (dpm26) enhancer elements contain tandem duplications that include the remaining wild-type element. These simple tandem duplications can create enhancers 25-fold more active than that of the parental mutant. These revertants can arise by illegitimate recombination between heterologous viral genomes. This was demonstrated by the recombinants resulting from a mixed infection with the viruses dpm16 and dpm2, which contain mutations in the A and C elements and the B element, respectively.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822961      PMCID: PMC255952          DOI: 10.1128/JVI.61.11.3536-3542.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Nucleotide sequence of the Hind-C fragment of simian virus 40 DNA. Comparison of the 5'-untranslated region of wild-type virus and of some deletion Mutants.

Authors:  H Van Heuverswyn; W Fiers
Journal:  Eur J Biochem       Date:  1979-10

2.  The SV40 enhancer can be dissected into multiple segments, each with a different cell type specificity.

Authors:  S Schirm; J Jiricny; W Schaffner
Journal:  Genes Dev       Date:  1987-03       Impact factor: 11.361

3.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

4.  The SV40 72 base repair repeat has a striking effect on gene expression both in SV40 and other chimeric recombinants.

Authors:  P Moreau; R Hen; B Wasylyk; R Everett; M P Gaub; P Chambon
Journal:  Nucleic Acids Res       Date:  1981-11-25       Impact factor: 16.971

5.  Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences.

Authors:  J Banerji; S Rusconi; W Schaffner
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

6.  Host-specific activation of transcription by tandem repeats from simian virus 40 and Moloney murine sarcoma virus.

Authors:  L A Laimins; G Khoury; C Gorman; B Howard; P Gruss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

7.  Multiple point mutations affecting the simian virus 40 enhancer.

Authors:  H Weiher; M König; P Gruss
Journal:  Science       Date:  1983-02-11       Impact factor: 47.728

8.  A small segment of polyoma virus DNA enhances the expression of a cloned beta-globin gene over a distance of 1400 base pairs.

Authors:  J de Villiers; W Schaffner
Journal:  Nucleic Acids Res       Date:  1981-12-11       Impact factor: 16.971

9.  Sequence heterogeneity in closed simian virus 40 deoxyribonucleic acid.

Authors:  H T Tai; C A Smith; P A Sharp; J Vinograd
Journal:  J Virol       Date:  1972-02       Impact factor: 5.103

10.  cis and trans activation of globin gene transcription in transient assays.

Authors:  R Treisman; M R Green; T Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

View more
  4 in total

1.  Stable growth of simian virus 40 recombinants containing multimerized enhancers.

Authors:  B Ondek; W Herr
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

2.  Simian virus 40 revertant enhancers exhibit restricted host ranges for enhancer function.

Authors:  A Shepard; J Clarke; W Herr
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

3.  YB-1 binds to the MMP-13 promoter sequence and represses MMP-13 transactivation via the AP-1 site.

Authors:  Shaija Samuel; Katherine K Beifuss; Lori R Bernstein
Journal:  Biochim Biophys Acta       Date:  2007-08-01

4.  Functional similarities between human immunodeficiency virus type 1 and simian virus 40 kappa B proto-enhancers.

Authors:  W Phares; W Herr
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.